This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Koninklijke Philips Corporation N.v., Other. Active years: 2018-2025.
Company Filing History:
1 out of 21,871 
1 out of 834,411 Years Active: 2018-2025
Title: Innovations and Contributions of Inventor George Baillie
Introduction
George Baillie is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of medical research, particularly in the areas of cancer treatment and neuropsychiatric disorders. With a total of 2 patents to his name, Baillie's work has the potential to impact patient care and treatment strategies.
Latest Patents
Baillie's latest patents include a method for pre-surgical risk stratification based on the expression of specific genes. This invention focuses on determining a gene expression profile for phosphodiesterase 4D variant 7 (PDE4D7) and DExH-box helicase 9 (DHX9) in biological samples from prostate cancer patients. The method aims to provide a pre-surgical prognostic risk score that can guide treatment decisions, such as whether to opt for active surveillance or radical prostatectomy.
Another significant patent involves methods for increasing DISC1 in subjects with schizophrenia or bipolar disorder. This invention identifies the interaction between DISC1 and the F-box-containing protein FBXW7, which mediates the turnover of DISC1. By providing antagonists that inhibit this interaction, the invention offers potential therapeutic avenues for treating neuropsychiatric disorders.
Career Highlights
Throughout his career, George Baillie has worked with prominent organizations, including Koninklijke Philips Corporation N.V. His experience in these companies has contributed to his innovative research and development efforts.
Collaborations
One of Baillie's notable collaborators is Ralf Dieter Hoffmann. Their partnership has likely fostered advancements in their respective fields, although specific details of their collaboration are not provided.
Conclusion
George Baillie's contributions to medical research through his patents demonstrate his commitment to improving patient outcomes in cancer treatment and neuropsychiatric disorders. His innovative approaches have the potential to shape future therapeutic strategies.